Obesity-Related Changes in Human Plasma Lipidome Determined by the Lipidyzer Platform

Dai, H., Alsalhe, T.A., Chalghaf, N., Ricco, M., Bragazzi, N.L., and Wu, J. (2020). The global burden of disease attributable to high body mass index in 195 countries and territories, 1990–2017: An analysis of the Global Burden of Disease Study. PLoS Med., 17.

(2020, December 05). Obesity and Overweight: Key Facts. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

(2020, December 05). Global Burden of Disease Compare. Available online: https://vizhub.healthdata.org/gbd-compare/.

Bays, 2013, Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association, J. Clin. Lipidol., 7, 304, 10.1016/j.jacl.2013.04.001

Klop, 2013, Dyslipidemia in obesity: Mechanisms and potential targets, Nutrients, 5, 1218, 10.3390/nu5041218

Knight, 2011, Diseases and disorders associated with excess body weight, Ann. Clin. Lab. Sci., 41, 107

Quehenberger, 2011, The human plasma lipidome, N. Engl. J. Med., 365, 1812, 10.1056/NEJMra1104901

Fahy, 2009, Update of the LIPID MAPS comprehensive classification system for lipids, J. Lipid. Res., 50, S9, 10.1194/jlr.R800095-JLR200

Beyene, H.B., Olshansky, G., AA, T.S., Giles, C., Huynh, K., Cinel, M., Mellett, N.A., Cadby, G., Hung, J., and Hui, J. (2020). High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies. PLoS Biol., 18.

Pietilainen, K.H., Sysi-Aho, M., Rissanen, A., Seppanen-Laakso, T., Yki-Jarvinen, H., Kaprio, J., and Oresic, M. (2007). Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects—A monozygotic twin study. PLoS ONE, 2.

Rauschert, 2016, Lipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults, J. Clin. Endocrinol. Metab., 101, 871, 10.1210/jc.2015-3525

Wang, 2019, Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity, Biomed. Res. Int., 2019, 1382418, 10.1155/2019/1382418

Yin, 2020, Lipidomic profiling identifies signatures of metabolic risk, EBioMedicine, 51, 102520, 10.1016/j.ebiom.2019.10.046

Mousa, 2019, Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1864, 335, 10.1016/j.bbalip.2018.12.014

Gil, 2019, Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies, Metabolomics, 15, 93, 10.1007/s11306-019-1553-y

Ubhi, 2018, Direct Infusion-Tandem Mass Spectrometry (DI-MS/MS) Analysis of Complex Lipids in Human Plasma and Serum Using the Lipidyzer Platform, Methods Mol. Biol., 1730, 227, 10.1007/978-1-4939-7592-1_15

Adany, R., Piko, P., Fiatal, S., Kosa, Z., Sandor, J., Biro, E., Kosa, K., Paragh, G., Bacsne Baba, E., and Veres-Balajti, I. (2020). Prevalence of Insulin Resistance in the Hungarian General and Roma Populations as Defined by Using Data Generated in a Complex Health (Interview and Examination) Survey. Int. J. Environ. Res. Public Health, 17.

Franko, A., Merkel, D., Kovarova, M., Hoene, M., Jaghutriz, B.A., Heni, M., Konigsrainer, A., Papan, C., Lehr, S., and Haring, H.U. (2018). Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation. Nutrients, 10.

Khan, 2020, Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasma, Rapid. Commun. Mass Spectrom., 34, e8911, 10.1002/rcm.8911

Brouwers, 2020, Lipid metabolism of leukocytes in the unstimulated and activated states, Anal. Bioanal. Chem., 412, 2353, 10.1007/s00216-020-02460-8

Liebisch, 2020, Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures, J. Lipid Res., 61, 1539, 10.1194/jlr.S120001025

Morigny, 2020, High levels of modified ceramides are a defining feature of murine and human cancer cachexia, J. Cachexia Sarcopenia Muscle, 11, 1459, 10.1002/jcsm.12626

Shah, 1991, Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. Conference report, Eur. J. Drug Metab. Pharmacokinet., 16, 249, 10.1007/BF03189968

Templeton, 2011, A Two-Step Approach for Transforming Continuous Variables to Normal: Implications and Recommendations for IS Research, Commun. Assoc. Inf. Syst., 28, 4

Jonckheere, 1954, A Distribution-Free k-Sample Test Against Ordered Alternatives, Biometrika, 41, 133, 10.1093/biomet/41.1-2.133

Ruopp, 2008, Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection, Biom. J., 50, 419, 10.1002/bimj.200710415

Castelli, 1992, Lipids and risk of coronary heart disease. The Framingham Study, Ann. Epidemiol., 2, 23, 10.1016/1047-2797(92)90033-M

(2006). The IDF Consensus Worldwide Definition of the Metabolic Syndrome, International Diabetes Federation.

Ain, 2018, To Determine Cutoff Value of Triglycerides to HDL Ratio in Cardio Vascular Risk Factors, Biochem. Anal. Biochem., 7, 1

Mach, 2020, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk, Eur. Heart J., 41, 111, 10.1093/eurheartj/ehz455

Avela, 2020, Advances in lipidomics, Clin. Chim. Acta, 510, 123, 10.1016/j.cca.2020.06.049

Ding, M., and Rexrode, K.M. (2020). A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins. Metabolites, 10.

Bowden, 2017, Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma, J. Lipid Res., 58, 2275, 10.1194/jlr.M079012

Sales, 2016, Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome, Sci. Rep., 6, 27710, 10.1038/srep27710

Quehenberger, 2010, Lipidomics reveals a remarkable diversity of lipids in human plasma, J. Lipid Res., 51, 3299, 10.1194/jlr.M009449

Montgomery, 2013, Contrasting metabolic effects of medium- versus long-chain fatty acids in skeletal muscle, J. Lipid Res., 54, 3322, 10.1194/jlr.M040451

Frayn, 2002, Adipose tissue as a buffer for daily lipid flux, Diabetologia, 45, 1201, 10.1007/s00125-002-0873-y

2015, The Physiological Regulation of Skeletal Muscle Fatty Acid Supply and Oxidation During Moderate-Intensity Exercise, Sports Med., 45, 23, 10.1007/s40279-015-0394-8

Silva Figueiredo, P., Carla Inada, A., Marcelino, G., Maiara Lopes Cardozo, C., de Cassia Freitas, K., de Cassia Avellaneda Guimaraes, R., de Castro, A.P., do Nascimento, V.A., and Hiane, P.A. (2017). Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders. Nutrients, 9.

Kojta, I., Chacinska, M., and Blachnio-Zabielska, A. (2020). Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Nutrients, 12.

Goodpaster, 2000, Intramuscular lipid content is increased in obesity and decreased by weight loss, Metabolism, 49, 467, 10.1016/S0026-0495(00)80010-4

Kelley, 1999, Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss, Am. J. Physiol., 277, E1130

Jones, 2003, Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue, Int. J. Obes. Relat. Metab. Disord., 27, 1565, 10.1038/sj.ijo.0802467

Mittendorfer, 2011, Origins of metabolic complications in obesity: Adipose tissue and free fatty acid trafficking, Curr. Opin. Clin. Nutr. Metab. Care, 14, 535, 10.1097/MCO.0b013e32834ad8b6

Candi, 2018, Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome, Biochem. J., 475, 1019, 10.1042/BCJ20170604

Wallner, 2011, Plasmalogens the neglected regulatory and scavenging lipid species, Chem. Phys. Lipids, 164, 573, 10.1016/j.chemphyslip.2011.06.008

Heilbronn, 2013, The effect of short-term overfeeding on serum lipids in healthy humans, Obesity, 21, E649, 10.1002/oby.20508

Donovan, 2013, Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean, Diabetol. Metab. Syndr., 5, 24, 10.1186/1758-5996-5-24

Braverman, 2012, Functions of plasmalogen lipids in health and disease, Biochim. Biophys. Acta, 1822, 1442, 10.1016/j.bbadis.2012.05.008

Ralston, 2014, Inhibition of stearoyl-CoA desaturase-1 in differentiating 3T3-L1 preadipocytes upregulates elongase 6 and downregulates genes affecting triacylglycerol synthesis, Int. J. Obes., 38, 1449, 10.1038/ijo.2014.35

Piers, 2002, The influence of the type of dietary fat on postprandial fat oxidation rates: Monounsaturated (olive oil) vs saturated fat (cream), Int. J. Obes. Relat. Metab. Disord., 26, 814, 10.1038/sj.ijo.0801993

Krishnan, 2014, Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans, Eur. J. Nutr., 53, 691, 10.1007/s00394-013-0638-z

Chew, 2019, Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence, JCI Insight., 5, e126925, 10.1172/jci.insight.126925

Sokolowska, 2019, The Role of Ceramides in Insulin Resistance, Front. Endocrinol., 10, 577, 10.3389/fendo.2019.00577

Hu, C., Luo, W., Xu, J., and Han, X. (2020). Recognition and Avoidance of Ion Source-Generated Artifacts in Lipidomics Analysis. Mass Spectrom. Rev.

Gathungu, 2018, Optimization of Electrospray Ionization Source Parameters for Lipidomics To Reduce Misannotation of In-Source Fragments as Precursor Ions, Anal. Chem., 90, 13523, 10.1021/acs.analchem.8b03436